Occult pancreatic ductal adenocarcinoma in patients undergoing invasive evaluation for chronic pancreatitis: A retrospective study
World Journal of Gastrointestinal Oncology · 15.11.2026 · 18 (11)
DOI: 10.4251/wjgo.123688 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Gastrointestinal Oncology, online erschienen am 15.11.2026. Verfasst von Wan-Zhen Wei und 9 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND Chronic pancreatitis (CP) is a well-established risk factor for pancreatic ductal adenocarcinoma (PDAC); however, the overlapping clinical and imaging features of the two conditions make early differentiation particularly challenging. AIM To identify independent risk factors for occult PDAC in patients with CP undergoing invasive diagnostic or surgical procedures. METHODS We conducted a retrospective cohort study of 359 patients with CP who underwent invasive diagnostic or surgical procedures between 2013 and 2023. Patients were classified according to histopathological findings obtained from surgical specimens or fine-needle biopsy. Clinical characteristics, radiological findings, and laboratory parameters were analyzed. Least absolute shrinkage and selection operator (LASSO) regression was applied for variable selection, followed by multivariable logistic regression to identify independent risk factors associated with PDAC. RESULTS Among the 359 patients with CP, 33 (9.20%) were histopathologically diagnosed with PDAC. LASSO regression identified pancreatic mass, main pancreatic duct stones, blood urea nitrogen, serum ionized calcium, carbohydrate antigen 19-9 (CA19-9), and carcinoembryonic antigen (CEA) as candidate factors. Multivariable logistic analysis demonstrated that elevated serum ionized calcium [odds ratio (OR) = 2.67, 95% confidence interval (95%CI): 1.23-6.88, P = 0.015], CA19-9 (OR = 2.83, 95%CI: 1.79-5.26, P < 0.001), and CEA (OR = 1.52, 95%CI: 1.05-2.17, P = 0.026) were independently associated with the presence of PDAC. CONCLUSION Among patients with CP requiring invasive procedures, 9.20% were histopathologically diagnosed with PDAC. Elevated serum ionized calcium, CA19-9, and CEA levels were identified as independent risk factors.
Zitieren
APA
Wei, W., Wei, K., He, H., Leng, H., Yang, X., Han, L., Jiang, Y., Xue, J., Wang, Z., & Duan, W. (2026). Occult pancreatic ductal adenocarcinoma in patients undergoing invasive evaluation for chronic pancreatitis: A retrospective study. World Journal of Gastrointestinal Oncology, 18(11). https://doi.org/10.4251/wjgo.123688
Vancouver
Wei W, Wei K, He H, Leng H, Yang X, Han L, et al. Occult pancreatic ductal adenocarcinoma in patients undergoing invasive evaluation for chronic pancreatitis: A retrospective study. World Journal of Gastrointestinal Oncology. 2026;18(11). doi:10.4251/wjgo.123688
BibTeX
@article{Wei2026,
author = {Wei, Wan-Zhen and Wei, Kong-Yuan and He, Hai-Rong and Leng, Hao-Ze and Yang, Xue and Han, Liang and Jiang, Yi-Na and Xue, Jing and Wang, Zheng and Duan, Wan-Xing},
title = {Occult pancreatic ductal adenocarcinoma in patients undergoing invasive evaluation for chronic pancreatitis: A retrospective study},
journal = {World Journal of Gastrointestinal Oncology},
year = {2026},
volume = {18},
number = {11},
doi = {10.4251/wjgo.123688}
}
EUVIMED